Breaking News - The Fly

Open Search

MXCT

MaxCyte

$

()

MaxCyte signs strategic platform license with Be BioPharma

MXCT

4/2/2024 - 08:27am

MaxCyte price target lowered by $2 at BTIG, here's why

MXCT

3/13/2024 - 07:09am

MaxCyte affirms FY24 guidance

MXCT

3/13/2024 - 07:08am

MaxCyte reports Q4 EPS (5c), consensus (7c)

MXCT

3/13/2024 - 07:07am

MaxCyte sees FY24 core revenue flat to up 5%, consensus $42.14M

MXCT

3/4/2024 - 16:24pm

MaxCyte backs FY23 core revenue view $41.1M-$41.3M, consensus $39.77M

MXCT

3/4/2024 - 16:22pm

MaxCyte, Wugen announced the signing of a strategic platform license

MXCT

1/30/2024 - 08:07am

MaxCyte signs strategic platform license with Imugene

MXCT

1/23/2024 - 08:15am

Fly Intel: After-Hours Movers

BARK , MXCT , MDXH

…

1/8/2024 - 17:35pm

MaxCyte jumps 13% to $5.19 after above-consensus Q4 pre-announcement

MXCT

1/8/2024 - 16:40pm

MaxCyte sees FY23 revenue $41.1M-$41.3M, consensus $36.72MM

MXCT

1/8/2024 - 16:23pm

MaxCyte sees Q4 revenue $15.5M-$15.7M, consensus $10.74M

MXCT

1/8/2024 - 16:21pm

MaxCyte, Lion TCR announces the signing of a strategic platform license

MXCT

1/3/2024 - 08:22am

MaxCyte appoints Maher Masoud as CEO

MXCT

1/2/2024 - 05:16am

MaxCyte backs FY23 core revenue view $28M-$30M, consensus $35M

MXCT

12/11/2023 - 16:08pm